COMMUNIQUÉS West-GlobeNewswire
-
Vireo Growth Receives Regulatory Approval and Completes Acquisition of PharmaCann Colorado Retail Assets
07/08/2026 -
FDA Completes First-Cycle Review of Preservative-Free Ketamine ANDA with No Drug Related Major Deficiencies; Final Packaging Certification Requested for Approval
07/08/2026 -
Rapid Micro Biosystems Reports Second Quarter 2026 Financial Results
07/08/2026 -
ANI Pharmaceuticals Reports Record Second Quarter 2026 Financial Results
07/08/2026 -
Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter 2026
07/08/2026 -
Bavarian Nordic Receives European Commission Approval of Mpox/Smallpox Vaccine for Children Aged 2 to Less than 12 Years
07/08/2026 -
National Health Sanitary Association Announces United Nations Procurement and Partnership Registration
07/08/2026 -
CancerVax Achieves Major Milestone in Activating Human Killer T-Cells Against Cancer
07/08/2026 -
BlossomHill Therapeutics Announces Pricing of Upsized $150 Million Initial Public Offering
07/08/2026 -
Latigo Biotherapeutics Announces Pricing of Upsized $345.6 Million Initial Public Offering
07/08/2026 -
Better U Expands 2026 Patient Eligibility, Safety and Treatment Access Information for At-Home Ketamine Therapy
07/08/2026 -
Starling Oncology Reports Second Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance
06/08/2026 -
Profound Medical Reports Second Quarter 2026 Financial Results
06/08/2026 -
Nephros Announces Strong Financial Results for Quarter Ended June 30, 2026
06/08/2026 -
TerrAscend Reports Second Quarter 2026 Financial Results
06/08/2026 -
Solid Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Updates
06/08/2026 -
Oculis Reports Q2 2026 Financial Results and Provides Company Update
06/08/2026 -
Oculis Reports Q2 2026 Financial Results and Provides Company Update
06/08/2026 -
CVRx Reports Second Quarter 2026 Financial and Operating Results
06/08/2026
Pages